Business

AmInvestment maintains ‘hold’ call on IHH despite PNB’s share placement news

News report claims PNB to place out some of its shares in the healthcare giant

Updated 5 years ago · Published on 18 Oct 2021 3:20PM

AmInvestment maintains ‘hold’ call on IHH despite PNB’s share placement news
PNB owns around 5.5% stake in IHH, AmInvestment says citing PNB’s annual report 2020. – IHH Healthcare Facebook pic, October 18, 2021

KUALA LUMPUR – AmInvestment Bank Bhd has maintained its “hold” call on IHH Healthcare Bhd (IHH) with an unchanged fair value (FV) of RM6.29.

This was despite news over the weekend that Permodalan Nasional Bhd (PNB) is placing out some of its shares in IHH.

“We are neutral on the news pending a formal announcement on the placement,” it said in a research note today.

According to AmInvestment, local financial news portal The Edge Malaysia Weekly, citing a source familiar with the matter, reported that PNB is placing out some of its shares in IHH.

“Based on its annual report 2020, PNB (through its various funds and subsidiaries) owns around 5.5% stake in IHH. 

The top three shareholders of IHH are Mitsui & Co Ltd (32.90%), Khazanah Nasional Bhd (25.81%) and the Employees Provident Fund (8.30%) as at March 31, 2021,” the research note said.

On IHH’s share performance, AmInvestment said the share price has done well this year with a year-to-date gain of 22% to RM6.72 from RM5.50, supported by its strong earnings before interest, taxes, depreciation, and amortisation (EBITDA) growth in the first half of 2021 (H1 2021) which surged 107% to RM2.07 billion.

On the third quarter of 2021 (Q3 2021) outlook, the investment bank reiterated its view that earnings for the quarter should see a q-o-q decline due to the expectation of lower earnings from its laboratory business.

“Covid-19 daily new cases in India have eased to about 20,000 cases in September from a peak of about 400,000 cases in May.

“This should result in lower revenue for IHH laboratory (business) in Q3 2021 due to fewer Covid-19 tests,” it said.

Although the number of elective surgeries may increase in Q3 2021, it is expected that these would not be enough to offset the impact of the lower earnings from laboratory tests.

According to the investment bank, India has the highest number of labs at over 420, accounting for 87% of the total 483 labs of the company in four key markets.

IHH’s laboratory sector generated a revenue of RM975 million in H1 2021.

At 10.45am, IHH shares rose six sen to RM6.78 with 665,300 shares changing hands. – Bernama, October 18, 2021  

Related News

Malaysia / 1mth

Flying Doctor Service to continue despite fatal Sarawak crash

Business / 1mth

Property developer, Matrix Concepts sets RM1.8b FY2027 sales target

Malaysia / 3mth

Malaysia’s hidden debt trap: When borrowing becomes a way of life

Business / 4mth

KPJ posts strong FY2025 performance, sets sights on next growth phase

Events / 4mth

KPJ rolls out first in-house kidney transplant service, starting with Tawakkal Specialist Hospital

Malaysia / 4mth

Sarawak seeks China collaboration to fix growing doctor shortage

Spotlight

Malaysia

Papagomo acquitted for second time in sedition case over government, Israel claims

Malaysia

ECRL fares start at RM60, with 50% discounts for children, seniors and OKU

Malaysia

DKU seeks court action against Ismail, 16 others over Negeri Sembilan royal dispute

By Alfian Z.M. Tahir

Malaysia

Kampung Manis: Dreams of 227 families to own replacement homes draw closer

Malaysia

Fadhlina takes legal action over video of 2023 Parliament speech

By Alfian Z.M. Tahir

Malaysia

Civil servants urged to turn Selangor Sultan’s anti-graft message into action

Malaysia

Animal welfare group urges probe into alleged sexual abuse of cat in viral video

Malaysia

Macron appeals for calm after France riots: 2,400 arrested, nearly 1,000 officers injured

Malaysia

Malaysia renews offer to help Indonesia fight fires

You may be interested

Business

Nation’s trade surplus hits RM232.4b in nine months as exports surge 34%

Business

Malaysia pushes chip-design startups to turn technology into global sales